Søgning
Søgning på udtrykket 'herpes simplex' giver 26 resultater
Dokumenter [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [5]
Dokumenter [1]
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Se…
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
AIDS
11.06.2025
Objective: . We investigate the risk of acquiring HIV or HSV-2 among young women who sell sex (YWSS) in rural South Africa. Design: . A representative population-based prospective cohort study of adolescent girls and young women (AGYW). Methods: . Between 2017 and 2019 we interviewed a random sample of AGYW (13–30 years) annually and collected dried blood spot samples for HIV and HSV-2 serology. YWSS were defined as engaging in transactional sex and/or sex work in the past 12 months…
Proceedings of the National Academy of Sciences
5.06.2025
Proceedings of the National Academy of Sciences, Volume 122, Issue 22, June 2025. SignificanceCyclic GMP-AMP synthase (cGAS) is an essential adaptor protein required for the inflammatory response to cytosolic DNA. dsDNA activates cGAS to generate cGAMP and activate STING and the expression of cytokines to control viral infection.
Proceedings of the National Academy of Sciences: Immunology and Inflammation
28.05.2025
Proceedings of the National Academy of Sciences, Volume 122, Issue 22, June 2025. SignificanceCyclic GMP-AMP synthase (cGAS) is an essential adaptor protein required for the inflammatory response to cytosolic DNA. dsDNA activates cGAS to generate cGAMP and activate STING and the expression of cytokines to control viral infection.
Journal of Infectious Diseases
27.05.2025
Abstract . The ability of herpes simplex virus (HSV) to establish lifelong latency in sensory neurons makes it one of the most pervasive viruses worldwide. Although most HSV infections are asymptomatic or cause limited cutaneous symptoms, some give rise to serious central nervous system (CNS) manifestations. Both primary HSV infection and subsequent reactivation events can cause viral replication and spread within the brain, ultimately leading to pathologic inflammation and direct CNS damage…
BMJ Open
21.05.2025
. Objective. A growing body of evidence points to a role for herpesviruses in the development of Alzheimer’s disease (AD) and a reduced risk of AD among patients receiving antiherpetic medications. We investigated the association between herpes simplex virus type 1 (HSV-1) and AD using real-world data (RWD) from USA. . Design. In a matched case–control study, patients with AD aged ≥50 years diagnosed between 2006 and 2021 were identified from the IQVIA PharMetrics Plus claims database…
Clinical Infectious Diseases
14.05.2025
Clinical Microbiology and Infection
10.05.2025
Antiviral drug resistance in herpes simplex virus 1 and 2 (HSV-1 & 2) is a significant clinical challenge, particularly in immunocompromised patients. Drug susceptibility testing (DST) aids clinical management and can be conducted through genotypic (partial genome sequencing) or phenotypic (cell culture) methods…
BMJ Open
20.04.2025
. Introduction. Herpes simplex virus 1 (HSV-1) infects approximately two-thirds of the global population under the age of 50 years. Although widely prevalent, the possible implications of HSV-1 in neurodegenerative diseases, especially dementia and Alzheimer’s disease, remain poorly understood. This review seeks to elucidate this association and explore the potential benefits of preventing or treating herpesvirus infections on dementia risk…
Journal of Infectious Diseases
26.03.2025
Abstract . Background . Herpes simplex virus type 1 (HSV-1) is a highly infectious, globally prevalent lifelong infection. Despite advancements in understanding its epidemiology, the assortativeness in the age-dependent transmission patterns remains unclear. This study aimed to estimate the degree of assortativeness in age group mixing for oral-to-oral HSV-1 transmission within the United States (U.S.) population.Methods …
Clinical Microbiology Reviews
22.02.2025
Clinical Microbiology Reviews, Ahead of Print.
Journal of Medical Virology
12.02.2025
Journal of Medical Virology, Volume 97, Issue 2, February 2025.
Clinical Microbiology and Infection
1.02.2025
Herpes simplex virus (HSV) infection is a clinically significant complication in hematopoietic cell transplant (HCT) recipients. Refractory and resistant (R/R) HSV infections may occur in this patient population, particularly after prolonged exposure to anti-HSV agents.
Clinical Infectious Diseases
30.01.2025
Abstract . Herpes simplex virus (HSV) infection is one of the most prevalent viral infections worldwide. In general, host immunity is sufficient to clear viral shedding and recurrences, although it is insufficient to prevent subsequent virologic reactivations. In immunocompromised patients, prolonged and difficult-to-treat HSV infections may develop. The diagnosis of refractory HSV infection is based on the lack of clinical response to nucleoside analogs…
Journal of Infectious Diseases
16.01.2025
Abstract . Background . Human papillomavirus (HPV) is a leading cause of cervical cancer, with 14 subtypes classified as high-risk human papillomavirus (HR-HPV). Despite the availability of vaccines, certain regions still experience limited access. Herpes simplex virus type II (HSV-II), a common sexually transmitted infection, is hypothesized to increase the risk of HR-HPV infections…
Journal of Medical Virology
22.11.2024
Journal of Medical Virology, Volume 96, Issue 11, November 2024.
Journal of Medical Virology
13.11.2024
Journal of Medical Virology, Volume 96, Issue 11, November 2024.
BMC Infectious Diseases
7.11.2024
. Abstract. Herpes Simplex Virus-1 (HSV-1) Kaposi varicelliform eruption (KVE) is a rare and severe cutaneous manifestation, clinically characterized by the presence of widespread vesicles and pustules. A case report details a patient with a history of Atopic Dermatitis (AD) and recent SARS-CoV-2 infection who developed a severe KVE subsequent to the viral illness…
PLoS One Infectious Diseases
15.10.2024
by The PLOS ONE Editors .
Journal of Medical Virology
4.10.2024
Journal of Medical Virology, Volume 96, Issue 10, October 2024.
Journal of Medical Virology
24.09.2024
Journal of Medical Virology, Volume 96, Issue 9, September 2024.
Aktuelle smitsomme sygdomme [5]
Aktuelle smitsomme sygdomme [5]
Medscape Infectious Diseases
21.05.2025
Dr Perry Wilson comments on findings that herpes simplex virus 1 infection doubles the risk for Alzheimer’s disease. . Medscape
ProMED
11.04.2025
…ar testing with PCR was done for. adeno-associated virus (AAV)2, HAdV, HAdV species F40/41 (in NVRL),. cytomegalovirus (CMV), Epstein-Barr virus (EBV), enterovirus,. hepatitis A virus (HAV), hepatitis C virus (HCV), hepatitis E virus. (HEV), HHV-6, HHV-7, herpes simplex virus (HSV) type 1, parechovirus. and parvovirus B19. Serological testing was done for CMV, EBV viral. capsid antigen (VCA), nuclear antigen 1 of EBV (EBNA), HAV, hepatitis…
ProMED
2.02.2025
…l OROV congenital infections. The study population consisted. of infants born in Brazil with samples from 2015-2021 and 2024. Serum. and cerebrospinal fluid (CSF) from this case series were analysed for:. syphilis, toxoplasmosis, rubella, cytomegalovirus, herpes simplex,. HIV, Zika, dengue, and chikungunya. Individuals that were negative for. these pathogens were then tested for OROV. Pathogen testing included. ELISA and haemagglutination inhibition testing for antibodies and. RT-PCR for virus RNA. …
Medscape Infectious Diseases
9.01.2025
Mild traumatic brain injury leads to reactivation of herpes simplex virus type 1, which may promote neurodegeneration and contribute to Alzheimer’s, new research suggested. . Medscape Medical News
Medscape Infectious Diseases
12.09.2024
British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be. . Reuters Health Information